期刊文献+

单核细胞趋化蛋白-1在一氧化氮缺乏性高血压肾损害大鼠中的作用

The Role of MCP-1 in Hypertensive Renal Injury of NO-deficient Rat
下载PDF
导出
摘要 目的研究单核细胞趋化蛋白-1(MCP-1)在一氧化氮(NO)缺乏性高血压肾损害大鼠中的作用。方法持续给予大鼠NO合酶抑制剂N-硝基-L-精氨酸甲酯(N-Nitro-L-Argininemethyl easter,L-NAME)造成高血压性肾损害大鼠模型(高血压组,n=10),同时选择正常大鼠作对照组(n=10)。8周后在普通光学显微镜下观察肾脏病理变化;观察24 h尿蛋白、尿β2微球蛋白,血清肌酐(Cr),血清和肾组织血管紧张素Ⅱ(AngⅡ)的变化。采用West-ern blotting分析MCP-1蛋白在肾脏表达的差异。结果与对照组比较,8周时高血压组24 h尿蛋白、尿β2微球蛋白,血清肌酐明显增加;普通病理分析发现肾小球硬化指数、间质纤维化指数明显升高;肾脏局部AngⅡ(96.2±18.3 vs 45.3±14.6,P<0.01)、MCP-1水平(3.68±0.25 vs 1.76±0.34,P<0.05)明显升高。结论 MCP-1在NO缺乏所致的高血压性肾损害中发挥着重要的作用,其机制可能与AngⅡ-MCP-1-细胞外基质(ECM)有关。 Objective To study the role of MCP-1 in hypertensive renal injury of NO-deficient Rat.Methods The model of NO-deficient hypertesive renal injury rat was made by giving heavy dose (N-Nitro-L-Argininemethyl easter,L-NAME)(hypertension group,n=10).Rats were sacrificed after 8 weeks.The renal tissues pathologic change was investgated with light microscope.24 h urinary protein(Up) and β2-microglobucin(β2-m) exeretion were measured.The level of Cr was measured in plasma.The level of angiotensin Ⅱ(AngⅡ) were measured in plasma and renal tissue.The difference of monocyte chemoattractant protein-1(MCP-1) was compared with control group in renal tissue through western blotting.Results As compared to control group,Up and β2-m showed significantly increased at week 8 in hypertension group;Glomerulosclerosis and interstitial fibrosis index elevated apparently in renal tissue of hypertension group;AngⅡ(96.2±18.3 vs 45.3±14.6,P〈0.01) and MCP-1(3.68± 0.25 vs 1.76±0.34,P〈0.05)stayed significant high level in renal tissue of hypertension group.Conclusions MCP-1 plays an important role in the development of hypertensive renal injury induced by NO-deficient,and AngⅡ-MCP-1-ECM axis maybe a major pathological feature in the modle.
出处 《南昌大学学报(医学版)》 CAS 2010年第4期35-37,42,共4页 Journal of Nanchang University:Medical Sciences
关键词 一氧化氮 高血压 肾损害 单核细胞趋化蛋白-1 动物 实验 大鼠 NO hypertension renal injury MCP-1 animals laboratory rats
  • 相关文献

参考文献1

二级参考文献7

  • 1[1]Zatz R, Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension, 1998, 32:958~ 964
  • 2[2]Nosratola D. Vaziri, Yaoxian Ding, Zhenmin Ni. Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension, 1999,34:559~562
  • 3[3]Porush JG. Hypertension and chronic renal failure: the use of ACE inhibitors. AM J Kidney Dis, 1998, 31:177 ~ 184
  • 4[4]Shanley PF. The pathology of chronic renal ischemia [ J ].Semin Nephrol, 1996,16(1) :21 ~ 32
  • 5[5]Wolf G, Neilson EG. Angiotensin Ⅱ as a renal growth factor. J Am Soc Nephrol,1993, 2:1531 ~ 1540
  • 6[6]Gordon Mclnnes. Angiotensin Ⅱ Antagonists [ M ] London:Science Press lid, 1998:1 ~ 39
  • 7[7]Navar LG, Imig JD, Zou L, et al. Intrarenal production of angiotensin Ⅱ [J]. Semin Nephrol, 1997, 17:412~422

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部